Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 6/20 | 0.60 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.53 |
| ▸ | HDAC1 | Q13547 | 9/20 | 0.53 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.52 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.52 |
| ▸ | CDK7 | P50613 | 1/20 | 0.48 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.46 |
| ▸ | ABL1 | P00519 | 1/20 | 0.45 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | NAMPT | P43490 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL2273866 | 0.85 | ABCB1 (0.65) | ABCB1NTRK1HDAC1HDAC3HDAC2 | |
| SCHEMBL12369423 | 0.85 | ABCB1 (0.64) | ABCB1NTRK1HDAC1HDAC3HDAC2 | |
| SCHEMBL12369422 | 0.82 | ABCB1 (0.70) | ABCB1NTRK1HDAC1HDAC3HDAC2 | |
| SCHEMBL2273286 | 0.81 | ABCB1 (0.49) | ABCB1HDAC1HDAC3HDAC2NPC1 | |
| SCHEMBL12118144 | 0.76 | HDAC1 (0.53) | ABCB1NTRK1HDAC1HDAC3HDAC2 | |
| SCHEMBL12118188 | 0.74 | HDAC1 (0.62) | ABCB1NTRK1HDAC1HDAC3HDAC2 | |
| SCHEMBL4213733 | 0.73 | TRPV1 (0.45) | — | |
| SCHEMBL1317058 | 0.73 | HDAC1 (0.61) | ABCB1NTRK1HDAC1HDAC3HDAC2 | |
| SCHEMBL12117593 | 0.73 | MKNK1 (0.51) | ABCB1NTRK1HDAC1HDAC3HDAC2 | |
| SCHEMBL1317112 | 0.73 | HDAC1 (0.52) | ABCB1HDAC1HDAC3HDAC2ABCC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7999132-B2 | Anthranilic acid derivative or salt thereof | TOYAMA CHEMICAL CO., LTD. (JP) | 2011-08-16 | — | — | US | disclosed |
| US-20090240052-A1 | NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF | TOYAMA CHEMICAL CO., LTD. (JP) | 2009-09-24 | — | — | US | disclosed |
| EP-1820795-A1 | NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF | TOYAMA CHEMICAL CO., LTD. (JP) | 2007-08-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090240052-A1 | NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF | MMP13, MMP26, MMP11 | ABCB1 2740/4885NTRK1 4364/4885HDAC1 71/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.